解决方案Solutions
🏥 医院端Hospital 🛡️ 保险端Insurance 🏢 企业端Enterprise 💊 药企端Pharma
核心概念Concepts
预防结算Prevention Settlement 可结算证据Billable Evidence PSM 因果归因Causal Attribution
内容与资源Content
▶ 在线演示Live Demo Insights 媒体报道Press 关于我们About 申请合作Contact Us
语言Language
Press / Media

行业与媒体的关注Press & Industry Coverage

36Kr、动脉网、投资界等行业媒体对 ReHealth Core 预防医疗决策基础设施的独立报道与评价。Independent coverage of ReHealth Core's preventive medicine decision infrastructure by 36Kr, Vbdata, Pedaily, and other industry media.

数百家100s
媒体与公众号转载Media & WeChat reposts
5+
专业媒体独立报道Professional media reports
400万
种子轮融资（人民币）Seed Round (RMB)
2026
融资完成年份Year of funding
重点报道Featured Coverage
36Kr · 36氪2026.04
独家首发Exclusive
AI打通预防归因与结算闭环，「睿禾健康」完成种子轮融资ReHealth Closes Seed Round — AI Closes Prevention-to-Settlement Loop
36Kr 独家报道睿禾健康完成400万元种子轮融资，深度解析"预测-干预-PSM归因-结算"四环闭环平台的技术架构与商业逻辑。36Kr exclusive coverage of ReHealth's 4M RMB seed round, with deep analysis of the Predict-Intervene-Attribute-Settle platform architecture and business logic.
阅读原文 ↗Read Original ↗
动脉网Vbdata / 动脉网2026.04
首发First Release
【首发】睿禾健康完成种子轮融资，全球首个预防医疗"预测-干预-归因-结算"闭环平台ReHealth — World's First Prevention-Attribution-Settlement AI Platform
动脉网首发报道，详述睿禾健康的技术路径、团队背景、市场定位，以及作为全球首个将预防归因结果直接对接支付结算的AI平台的核心壁垒。Vbdata first-release coverage detailing ReHealth's technical path, team, market positioning, and core barriers as the world's first AI platform connecting prevention attribution to payment settlement.
阅读原文 ↗Read Original ↗
全部报道All Coverage
36Kr
AI打通预防归因与结算闭环，「睿禾健康」完成种子轮融资ReHealth Closes Seed Round — AI Closes Prevention-to-Settlement Loop
2026.04
↗
动脉网Vbdata
【首发】睿禾健康完成种子轮融资，全球首个预防医疗"预测-干预-归因-结算"闭环平台ReHealth — World's First Prevention-to-Settlement AI Platform
2026.04
↗
投资界Pedaily
预防医疗AI公司「睿禾健康」完成种子轮融资Preventive Medicine AI Company ReHealth Closes Seed Round
2026.04
↗
DoNews
睿禾健康完成400万元种子轮融资ReHealth Closes 4M RMB Seed Round
2026.04
↗
医药魔方PharmCube
【首发】睿禾健康完成种子轮融资，全球首个预防医疗"预测-干预-归因-结算"闭环平台ReHealth — World's First Prevention-to-Settlement Platform
2026.04
↗
"市场上不缺预测工具，缺的是把预防结果变成可结算证据的基础设施。PSM归因做的就是这件事——把干预有没有用这个问题，从一个说法变成一个可被验证、可被结算的数字。""The market has prediction tools. What's missing is infrastructure that converts prevention outcomes into billable evidence. PSM attribution does exactly this — it turns 'does the intervention work?' from a claim into a verifiable, billable number.""
陈沛钧，ReHealth Core 创始人兼CEO · 引自动脉网报道Peijun Chen, Founder & CEO of ReHealth Core · Quoted from Vbdata coverage

媒体合作与采访Media Collaboration & Interviews

如需采访、获取媒体素材、或了解更多产品信息，欢迎联系我们的媒体团队。For interviews, media materials, or more product information, please contact our media team.

联系媒体团队Contact Media Team →

了解更多Learn More

查看 ReHealth Core 的核心技术、解决方案和方法论文章，深入了解预防结算基础设施。Explore ReHealth Core's core technology, solutions, and methodology articles to understand prevention settlement infrastructure.

Insights 文章Read Insights 核心概念Core Concepts